Thyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis
Authors:
- H A SterleHSH A Sterle
- E ValliEVE Valli
- F CayrolFCF Cayrol
- M A PaulazoMPM A Paulazo
- D J Martinel LamasDLD J Martinel Lamas
- M C Diaz FlaquéMFM C Diaz Flaqué
- A J KlechaAKA J Klecha
- L ColomboLCL Colombo
- V A MedinaVMV A Medina
- G A CremaschiGCG A Cremaschi
- M L Barreiro ArcosMAM L Barreiro Arcos
Open Access
- 13 June 2014
- journal article
- research article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 222 (2) , 243-255
Abstract
We have shown in vitro that thyroid hormones (THs) regulate the balance between proliferation and apoptosis of T lymphoma cells. The effects of THs on tumor development have been studied, but the results are still controversial. Herein, we show the modulatory action of thyroid status on the in vivo growth of T lymphoma cells. For this purpose, euthyroid, hypothyroid, and hyperthyroid mice received inoculations of EL4 cells to allow the development of solid tumors. Tumors in the hyperthyroid animals exhibited a higher growth rate, as evidenced by the early appearance of palpable solid tumors and the increased tumor volume. These results are consistent with the rate of cell division determined by staining tumor cells with carboxyfluorescein succinimidyl ester. Additionally, hyperthyroid mice exhibited reduced survival. Hypothyroid mice did not differ significantly from the euthyroid controls with respect to these parameters. Additionally, only tumors from hyperthyroid animals had increased expression levels of proliferating cell nuclear antigen and active caspase 3. Differential expression of cell cycle regulatory proteins was also observed. The levels of cyclins D1 and D3 were augmented in the tumors of the hyperthyroid animals, whereas the cell cycle inhibitors p16/INK4A (CDKN2A) and p27/Kip1 (CDKN1B) and the tumor suppressor p53 (TRP53) were increased in hypothyroid mice. Intratumoral and peritumoral vasculogenesis was increased only in hyperthyroid mice. Therefore, we propose that the thyroid status modulates the in vivo growth of EL4 T lymphoma through the regulation of cyclin, cyclin-dependent kinase inhibitor, and tumor suppressor gene expression, as well as the stimulation of angiogenesis.Keywords
This publication has 49 references indexed in Scilit:
- Induction of apoptosis in T lymphoma cells by long-term treatment with thyroxine involves PKCζ nitration by nitric oxide synthaseApoptosis, 2013
- MECHANISMS IN ENDOCRINOLOGY: Primary HT and risk for breast cancer: a systematic review and meta-analysisEuropean Journal of Endocrinology, 2012
- Cooperative nongenomic and genomic actions on thyroid hormone mediated-modulation of T cell proliferation involve up-regulation of thyroid hormone receptor and inducible nitric oxide synthase expressionJournal of Cellular Physiology, 2011
- Molecular Aspects of Thyroid Hormone ActionsEndocrine Reviews, 2010
- p27 Deficiency Cooperates with Bcl-2 but Not Bax to Promote T-Cell LymphomaPLOS ONE, 2008
- Thyroid hormone inhibits proliferation of fetal cardiac myocytes in vitroJournal of Endocrinology, 2007
- Thyroid hormone and breast carcinomaCancer, 2005
- Thyroid Status Affects Rat Liver Regeneration After Partial Hepatectomy by Regulating Cell Cycle and ApoptosisCellular Physiology and Biochemistry, 2005
- Expression of Cyclin-Dependent Kinase Inhibitors in Epiphyseal Chondrocytes Induced to Terminally Differentiate with Thyroid HormoneEndocrinology, 2000
- Frequent Methylation Silencing of p15INK4b(MTS2) and p16INK4a (MTS1) in B-Cell and T-Cell LymphomasBlood, 1999